LSP raises $600m for latest European life sciences fund

The fund, called LSP 6, will invest in between 15 and 18 private companies that are developing new medications or medical technologies

Read Previous

Oil price dive puts private equity billions at risk

Read Next

KKR temporarily closes London offices after coronavirus case

Leave a Reply

Your email address will not be published. Required fields are marked *

Most Popular

We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.
We use cookies to offer you a better browsing experience. If you continue to use this site, you consent to our use of cookies.